XENE- Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. (XENE) has 5 insiders with recent SEC Form 4 filings, including 30 buys and 1 sell. XENE is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 30.0K | $1.64M | - | |
| Other | 20.0K | $1.10M | - | |
| CEO | 19.9K | $1.09M | - | |
| Other | 7.3K | $400.0K | - | |
| Other | 7.1K | $387.3K | - |
Activity
Buys and sells only
Transactions
10 filings · page 6
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2017 | Mortimer Ian57 | CFO &COO | Buy | 15,000 | $2.88 | $43,225.00 | +283.0% | |
| Aug 10, 2017 | Pimstone Simon N.60 | President &CEO | Buy | 6,000 | $2.90 | $17,400.00 | +2.8% | |
| Aug 10, 2017 | Scheller Richard H90 | Director | Buy | 7,000 | $2.85 | $19,950.00 | New | |
| Aug 10, 2017 | Patou Gary50 | Director | Buy | 7,500 | $2.78 | $20,835.75 | +150.0% | |
| Aug 8, 2017 | Patou Gary50 | Director | Buy | 5,000 | $3.00 | $15,002.50 | New | |
| Jun 27, 2017 | Bvf Partners L P/il59 | 10% Owner | Buy | 85,461 | $4.00 | $341,844.00 | +2.9% | |
| Jun 22, 2017 | Bvf Partners L P/il59 | 10% Owner | Buy | 20,411 | $4.00 | $81,644.00 | +0.4% | |
| Jun 19, 2017 | Bvf Partners L P/il59 | 10% Owner | Buy | 26,408 | $3.84 | $101,517.67 | +0.3% | |
| Jun 7, 2017 | Bvf Partners L P/il59 | 10% Owner | Buy | 358,698 | $3.81 | $1,366,145.75 | +7.0% | |
| Dec 15, 2016 | Holler Frank A | Director | Sell | 30,000 | $7.85 | $235,500.00 | -20.6% |